|Previous Section||Back to Table of Contents||Lords Hansard Home Page|
Lord McIntosh of Haringey: Sport England provide an annual grant to the English Federation for Disability Sport (EFDS) with the aim of leading a coordinated and unified approach to disability sport in England. They act as an umbrella group for the seven disability organisations recognised by Sport England. The groups are:
Lord McIntosh of Haringey: At this time, the UK Government do not intend to approach pharmaceutical companies to sponsor the work of the UK's anti-doping agency. We are awaiting the outcome of the review of UK Sport's functions, which includes the role and responsibility for anti-doping arrangements in the UK, before we make any decisions on how the national anti-doping policy should best be delivered.
The Parliamentary Under-Secretary of State, Department of Health (Lord Warner): Regulation 14(8) of the Domiciliary Care Agencies Regulations 2003 requires agencies to make suitable arrangements, by training or other measures, to ensure that domiciliary care workers operate a safe system of working, including in relation to lifting and moving service users. National minimum standards on domiciliary care are taken into account by the National Care Standards Commission in determining whether the requirements of regulations are met.
Lord Warner: Waiting times information is collected from all National Health Service trusts and primary care trusts where these organisations provide either a consultant-led inpatient service or a consultant-led outpatient service or both. The information is collected at speciality level and covers waits for elective inpatient admission and first consultant outpatient appointment following general practitioner or general dental practitioner referral. The information is also collected on a commissioner basis and primary care trusts submit specialty level data on patients waiting for services for which they have commissioned.
Lord Warner: The current outpatient waiting time target applies to patients waiting for their first outpatient appointment with a consultant following a general practitioner or general dental practitioner does not include consultant-to-consultant, nurse-to-consultant or any other referrals.
Lord Warner: In 1997 Carillion was awarded the contract for the Dartford and Gravesham National Health Service Trust private finance initiative project, now known as the Darent Valley Hospital. They invested £4.1 million in the project company established to carry out the contract. In November 2003 Carillion announced that it had sold its share of the investment in the Darent Valley Hospital PFI scheme for £5.2 million.
In March 2003 the original loan taken out by the project company to finance the contract was replaced by a different loanthis resulted in a refinancing gain shared between the project company and the NHS trust. The NHS trust share of the benefits from this refinancing amounted to nearly £12 million.
While it is entirely right that the NHS trust should share in the refinancing gain, we would not expect it to benefit from the sale of equity in a project company by one private sector organisation to another.
What progress has been made in research leading to curing or arresting the spread of Huntingdon's disease in individual sufferers.[HL378]
Lord Warner: In 200203 the Medical Research Council spent around £2 million on research into Huntington's disease. The Wales Gene Park, funded by the Welsh Assembly Government and the Department of Trade and Industry, has a programme of work on neurogenetics and neuropsychiatric genetics. Currently research is focused on a number of disorders including Huntington's disease. The Department of Health is funding some research of relevance to Huntington's disease, including £1.6 million spent in 200203 on research into dementia.
The Chief Medical Officer's report, Stem Cell Research: medical progress with responsibility, published in 2000, considered the potential of embryonic stem cells as a source of new tissues for the treatment of neurological conditions including Huntington's disease. Such research is at a very early stage and it may be several years before therapeutic benefits are available. The Government have made available, through the research councils, £40 million over two years for stem cell research.
Lord Warner: The Office for National Statistics estimates that there are about 176 deaths each year from Huntington's disease. The Huntington's Disease Association estimates that it affects around one person in 10,000 in the United Kingdom.
Lord Warner: The organisations currently giving support to those suffering from Huntington's disease are the National Health Service and social services. Additional support is given by the Huntington's Disease Association, a voluntary organisation.
Lord Warner: Figures from the Health Survey for England, which each year surveys a sample of the general population, are set out in the table. Overall numbers of the population who are overweight or obese have been estimated from the health survey only for 2001. The table also gives the proportion of men and women who were overweight or obese in 1991, when the survey began, and 2001 and the percentage increase over that period.
The samples sizes in 1991 and 1992 were smaller than in subsequent years and for reporting purposes the estimates from both years were combined.